✨ Your Portfolio is fetched and updated from zerodha.
Large Pharmaceuticals

Divi's Laboratories Ltd.

DIVISLAB

Market Cap
₹1,62,735 Cr.
P/E
70.57

Divi's Laboratories Ltd.

  • Divi's Lab
  • Laurus Labs
  • Neuland Laboratories
  • TJI Pharma - API & CRAMS
FAQs on Divi's Laboratories Ltd. Shareprice

Divi's Lab has given lower returns compared to its competitors.
Divi's Lab has grown at ~29.53% over the last 2yrs while peers have grown at a median rate of 45.05%

Yes, Divi's Lab is expensive.
Latest PE of Divi's Lab is 70.57, while 3 year average PE is 59.37.
Also latest EV/EBITDA of Divi's Lab is 51.73 while 3yr average is 41.73.

View FAQ's On Business
Growth Table
  • Divi's Laboratories Ltd.
  • Laurus Labs
  • Neuland Laboratories
Balance Sheet
  • Divi's Laboratories Ltd.
  • Laurus Labs
  • Neuland Laboratories
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Divi's Laboratories Ltd.
  • Laurus Labs
  • Neuland Laboratories
Cash Flow
  • Divi's Laboratories Ltd.
  • Laurus Labs
  • Neuland Laboratories
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Divi's Laboratories Ltd.
  • Laurus Labs
  • Neuland Laboratories
Quarterly Results
  • Divi's Laboratories Ltd.
  • Laurus Labs
  • Neuland Laboratories
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Divi's Laboratories Ltd. Financials

Balance sheet of Divi's Lab is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Divi's Lab is increasing.
Latest debt of Divi's Lab is -₹7,427 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹7,959 Crs.

Yes, profit is increasing.
The profit of Divi's Lab is ₹2,306 Crs for TTM, ₹2,191 Crs for Mar 2025 and ₹1,600 Crs for Mar 2024.

The company seems to pay a good stable dividend.
Divi's Lab latest dividend payout ratio is 36.28% and 3yr average dividend payout ratio is 43.19%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech